Athyrium Capital Management and Esperion Enter Into $50 Million Japan Royalty Financing to Support Strategic Acquisition of Corstasis Therapeutics
HealthcareNew YorkOther
Athyrium Capital Management→Esperion Therapeutics
Apr 2, 2026
Athyrium Capital Management — Acquisitions & M&A Deals
1 dealTracking 1 M&A deal by Athyrium Capital Management.